AIR2 Trial

Related by string. * : AIR2 / trialed . trialing . trials . trial . Trials . TRIAL . TRIALS . trialer . Trialing : Phase III clinical trials . Week Premium Trial . placebo controlled clinical trials . Phase III trials . randomized controlled trial . randomized controlled trials . Phase III Clinical Trial . Trial Lawyers Association . randomized clinical trials . Trial . Phase IIa clinical trials * *

Related by context. Frequent words. (Click for all words.) 66 Multicenter 65 multicenter Phase 64 double blinded placebo 64 placebo controlled Phase 64 relapsing multiple sclerosis 64 placebo controlled clinical 64 SABCS 64 Chronic Heart Failure 64 prospective observational 64 Phase Ib clinical 63 prospective multicenter 63 PRECiSE 63 Clinical Trial Results 63 Diabetic Macular Edema 63 Phase III Clinical Trial 63 phase IIa 62 Phase III randomized 62 Lung Transplantation 62 pharmacokinetic PK 62 Pivotal Trial 61 Pivotal Phase 61 Pulmonary Arterial Hypertension 61 CROI 61 RRMS patients 61 forodesine 61 multicenter study 61 placebo controlled randomized 61 multicenter randomized double 61 Phase 2a clinical 61 phase IIb clinical 61 Molecular Cancer 61 Pirfenidone 61 Gynecologic Oncology Group 61 Panzem R 61 subanalysis 60 bronchial thermoplasty 60 nonrandomized 60 label dose escalation 60 Traficet EN 60 multicenter randomized 60 HSCT 60 Pivotal Phase III 60 EORTC 60 Vandetanib 60 PRECISE 60 blinded placebo controlled 60 Acute Myocardial Infarction 60 Pharmacokinetic 60 multicenter 60 Metastatic Melanoma 60 active comparator 60 placebo controlled trials 60 Phase 1b trial 60 glatiramer acetate 60 Anticoagulation 60 Amrubicin 60 randomized Phase III 60 Phase IIa trial 60 doripenem 60 Phase 2a trial 60 NLX P# 59 Natalizumab 59 registrational trial 59 liposomal formulation 59 Solid Tumors 59 Group ECOG 59 ZD# [001] 59 prospective randomized controlled 59 placebo controlled studies 59 Arch Neurol 59 ASCO Annual Meeting 59 Retisert 59 pertuzumab 59 COPAXONE R 59 relapsed refractory multiple myeloma 59 Overactive Bladder 59 Gastrointestinal Cancers Symposium 59 ACRIN 59 Chronic Hepatitis C 59 KRN# 59 SPIRIT IV 59 GSK# [001] 59 PROMACTA 59 KNS # 59 multicenter clinical 58 #th Annual Interscience 58 eszopiclone 58 Diabetic Patients 58 substudy 58 multicentre 58 metreleptin 58 placebo controlled clinical trials 58 axitinib 58 phase IIb 58 prospectively defined 58 Atopic Dermatitis 58 Clinical Oncology Annual Meeting 58 elotuzumab 58 PTNS 58 SHPT 58 liver transplant recipients

Back to home page